back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2026-04-02 13:29 Tx date 2026-03-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$34,896
+2,420 vol $14.42 each |
49,048 | |
| Filed 2026-04-02 13:28 Tx date 2026-03-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-4,840 vol |
46,628 | |
| Filed 2026-04-02 13:25 Tx date 2026-03-24 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+2,573 vol |
51,468 | |
| Older filings | ||||||
| Filed 2026-03-26 11:57 Tx date 2026-03-24 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
56 - Grant of rights
|
+2,573 vol |
||
| Filed 2026-03-26 11:57 Tx date 2026-03-24 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
56 - Grant of rights
|
+2,573 vol |
2,573 | |
| Filed 2026-03-26 11:53 Tx date 2026-03-24 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
56 - Grant of rights
|
+2,573 vol |
||
| Filed 2026-03-26 11:43 Tx date 2026-03-24 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
56 - Grant of rights
|
+2,573 vol |
||
| Filed 2026-03-20 15:56 Tx date 2025-12-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,467
+210 vol $11.75 each |
48,895 | |
| Filed 2026-03-20 15:54 Tx date 2025-12-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,819
+940 vol $11.51 each |
48,685 | |
| Filed 2025-04-01 09:19 Tx date 2025-03-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$21,307
+1,911 vol $11.15 each |
47,745 | |
| Filed 2025-04-01 09:16 Tx date 2025-03-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-3,823 vol |
45,834 | |
| Filed 2025-03-19 13:51 Tx date 2025-03-18 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+3,273 vol |
49,657 | |
| Filed 2025-03-11 10:56 Tx date 2024-12-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,024
+229 vol $8.84 each |
46,384 | |
| Filed 2025-03-11 10:53 Tx date 2024-12-31 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,105
+1,045 vol $9.67 each |
46,155 | |
| Filed 2024-12-16 15:29 Tx date 2024-12-16 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,394.64
-532 vol $12.02 each |
45,110 | |
| Filed 2024-12-16 15:28 Tx date 2024-12-16 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$5,836
+532 vol $10.97 each |
45,642 | |
| Filed 2024-12-16 15:26 Tx date 2024-12-16 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
51 - Exercise of options
|
$-5,836.04
-532 vol $10.97 each |
0 | |
| Filed 2024-12-16 15:24 Tx date 2024-12-16 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,432.76
-119 vol $12.04 each |
45,110 | |
| Filed 2024-12-16 15:21 Tx date 2024-12-12 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,594
-300 vol $11.98 each |
45,229 | |
| Filed 2024-09-23 11:34 Tx date 2024-09-20 |
$RX
BioSyent Inc. |
Ashrafi, Seyed Ahmad
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-27,473.55
-2,509 vol $10.95 each |
45,529 | |